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Abstract
Background This study aimed to estimate the cost-
effectiveness of a universal strategy to promote physical
activity in primary care.
Methods Data were analysed for a cohort of participants
from the general practice research database. Empirical
estimates informed a Markov model that included five
long-term conditions (diabetes, coronary heart disease,
stroke, colorectal cancer and depression). Simulations
compared an intervention promoting physical activity in
healthy adults with standard care. The intervention effect
on physical activity was from a meta-analysis of random-
ised trials. The annual cost of intervention, in the base case,
was one family practice consultation per participant year.
The primary outcome was net health benefit in quality
adjusted life years (QALYs).
Results A cohort of 262,704 healthy participants entered
the model. Intervention was associated with an increase in
life years lived free from physical disease. With 5 years
intervention the increase was 52 (95 % interval -11 to
115) per 1,000 participants entering the model (probability
increased 91.9 %); with 10 years intervention the increase
was 102 (42–164) per 1,000 (probability 99.7 %). Net
health benefits at a threshold of £30,000 per QALY were
3.2 (-11.1 to 16.9) QALYs per 1,000 participants with
5 years intervention (probability cost-effective 64.7 %)
and 5.0 (-9.5 to 19.3) with 10 years intervention (proba-
bility cost-effective 72.4 %).
Conclusions A universal strategy to promote physical
activity in primary care has the potential to increase life
years lived free from physical disease. There is only weak
evidence that a universal intervention strategy might prove
cost-effective.
Keywords Physical activity  Primary care  Markov
model  Outcomes  Cost-effectiveness  Depression 
Diabetes  Coronary heart disease  Stroke 
Colorectal cancer
JEL Classification I10 Health  General  D61 
Allocative efficiency
Introduction
Physical inactivity is one of the most important risk factors
for chronic disease [1]. Epidemiological studies show that
higher levels of physical activity are associated with lower
frequency of diabetes, coronary heart disease, stroke, colo-
rectal cancer and depression [1]. The promotion of physical
activity has become a key global public health objective [2].
Current recommendations recognise that there is a ‘clear link
between physical activity and chronic disease’ [3] and advise
that all adults should take at least 150 min of moderate
physical activity per week with daily activity. Achieving this
objective requires action through multiple sectors and at
different levels [4]. This research considers the role of pri-
mary care services in promoting physical activity.
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Health services increasingly emphasise healthy ageing,
aiming to prevent disease and reduce the impact of long-term
conditions in later life [5]. Primary care services have a
potentially important role to play in promoting physical
activity. A recent meta-analysis of randomised trials found
that brief interventions in primary care could result in one
additional person achieving recommended physical activity
levels for each 12 persons exposed to the intervention, with
the effect being maintained over 12 months [6]. Williams [7]
observed that ‘brief exercise advice has a small effect on
increasing physical activity… Such a small effect could be
important if carried out on a large population of patients’ [7].
The potential long-term effects of interventions to pro-
mote physical activity in primary care are not known.
Existing reviews have included studies up to 2 years
duration with behaviour change and physical fitness as
outcomes [6]. Evidence that increased physical activity
may reduce the incidence of diabetes is drawn from studies
that included high risk individuals with impaired glucose
tolerance or pre-diabetes [8]. The present research there-
fore aimed to evaluate the potential long term health out-
comes and cost effectiveness of a universal strategy to
promote physical activity in primary care. The research
specifically aimed to determine whether a low-cost inter-
vention with a limited intervention effect size, such as that
evidenced by the recent meta-analysis on the effectiveness
of such interventions [6], would prove cost-effective for
implementation across the general population through pri-
mary health care services.
Methods
Markov model structure
A Markov model was employed to implement a cost-utility
analysis of a universal strategy to promote physical activity in
the general population registered in primary care, comparing a
brief intervention to promote physical activity with ‘standard
care’ in which there is no systematic approach to promote
physical activity. A simplified diagram of the Markov model
is shown in Fig. 1. The model structure was informed by
previously reported research [9]. Healthy subjects, referred to
as ‘At Risk’, may develop one of the disease states of interest,
including Diabetes, Coronary Heart Disease, Stroke or
Colorectal Cancer. Participants in one of these disease states
may develop a second, third or fourth disease, giving 16 sin-
gle- or multi-disease states, consistent with the frequent
occurrence of multimorbidity as a driver of health care util-
isation in primary care populations [10]. Participants in each
state were allowed to progress to Depression, with each state
divided into states representing ‘Not Depressed’ and
‘Depressed’. Depression was associated with its own
decrement in utility as well as its own rate of health care
utilisation. Depression was included because it occurs fre-
quently in chronic illness and is associated with higher health
care costs for a given chronic illness [11]. There were there-
fore 32 states in the model that represented all potential
combinations of the included diseases and depression. All
states might lead to death. The perspective of the model is that
of health care services and only health care costs were inclu-
ded. A lifetime time horizon was used.
GPRD cohort
Data to populate the model were derived from a large
cohort of participants drawn from the general population
registered with the general practice research database
(GPRD) [12]. The GPRD includes electronic health records
of participants registered with approximately 600 UK
family practices. GPRD data were used to estimate the
incidence of each state included in the model; the mortality
in each state; and the health care utilisation and costs
associated with each state. The use of fully anonymised
GPRD data was approved by the MHRA Independent
Scientific Advisory Committee (Ref. 09-085).
The GPRD cohort was drawn from all family practices that
were continuously contributing data to the GPRD between 1
January 2004 and 30 October 2010. Participants comprised a
random sample of 299,912 registered patients, aged
30–100 years. Incidence and mortality rates were estimated,
by 10-year age group and sex. As colorectal cancer cases were
less numerous, we made the assumptions that the incidence of
colorectal cancer was the same in participants with and
without cardiovascular comorbidity, and the incidence of
cardiovascular comorbidity was the same in participants with
and without colorectal cancer. Incidence and mortality rates
were similar to those reported from GPRD previously
[13–15]. The prevalence of depression was estimated for each
state in the Model based on GPRD data [11]. In the Model, we
assumed that depression was not associated with mortality at
any given level of physical disease.
Health care utilisation was estimated for each state from
GPRD records, including utilisation of primary care
(family practice consultations, telephone consultations,
home visits and emergency and out-of-hours consulta-
tions), secondary care (including hospital admissions,
outpatient visits, day case visits and emergency visits) and
prescriptions. The annual costs associated with each state
were estimated by multiplying the health care utilisation
associated with the state by the costs of each unit of health
care, which were obtained from standard reference sources
for 2010 [16] (Table 1). Prescription costs were obtained
by linking the Multilex drug code for each prescription
record in GPRD with the prescription cost [17]. The
empirical mean (standard deviation) of participant level
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costs were estimated by age group, gender, depression
status and condition. As the number of colorectal cancer
cases was too small to subdivide into multi-disease states,
health care utilisation was estimated for all colorectal
cancer cases together.
Model estimation
The probabilistic Markov model was estimated by cohort
simulation, implemented through a program written in R
software [18]. After removing participants with prevalent
disease, there were 262,704 healthy participants that
entered the initial state of the Model, based on the distri-
bution observed in GPRD, including 49 % men. There
were 37 % aged \45 years and 42 % were aged
45–64 years. All simulations were stratified by single year
of age with the initial population aging by 1 year per cycle.
Participants exited the model when they died or reached
100 years of age. The model was run for each sex sepa-
rately. Outcomes and costs were compared for Intervention
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Fig. 1 Schematic diagram of Markov model. In order to simplify the diagram, the 32 incidence transitions and 16 mortality transitions are not
represented in full. Each state is further divided into ‘depressed’ and ‘not depressed’. CHD Coronary heart disease, DM type 2 diabetes mellitus
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Table 1 Sources of data for model
Data Number/value Source Stratification Comments
Base population 299,912 GPRD Gender, 1-year age
group
Participants with prevalent disease
were excluded. Age range
30–100 years
Model states 33 states Stratified by gender,
1-year age group.
Includes At Risk, Diabetes, CHD,
Stroke, Colorectal cancer,
Depression and all combinations,
dead
Incidence of states 32 incidence rates GPRD Gender, 10-year age
group
Beta-binomial distribution used to
estimate transition probabilities;
incidence assumed independent of
depression; note that the same state
may be reached by more than one
transition (e.g. CHD in diabetes,
diabetes in CHD)
Mortality of states 16 mortality rates GPRD Gender, 10-year age
group
Beta-binomial distribution used to
estimate transition probabilities;
mortality assumed independent of
depression
Depression
prevalence
16 depression
prevalence rates
GPRD Gender, 10-year age
group
Beta-binomial distribution used to
estimate transition probabilities
Health care utilization Utilisation rates
estimated for 32 states
GPRD Gender, 10-year age
group, depression
status
Utilisation included primary care
consultations (including at general
practice, home, telephone and out of
hours or emergency), secondary care
(including inpatient, outpatient, day
case and emergency) and
prescription number and content
Unit costs of health care utilization
Primary care
Consultation £35 PSSRU [16] Gamma distribution used to sample
costs
Emergency/out of
hours
consultation
£35 PSSRU [16]
Home visit £117 PSSRU [16]
Telephone
consultation
£21 PSSRU [16]
Prescription unit
costs
Variable FDBE [16] Unit price linked by Multilex code to
GPRD prescription. Single pack
price assumed
Secondary care
Inpatient episodes £493 PSSRU [16]
Outpatient visits £189 PSSRU [16]
Day case visits £143 PSSRU [16]
Emergency visits £110 PSSRU [16]
Utility values Utility decrement
Age 43 years 0.828 Sullivan et al. [19] Stratified by single year
of age
Beta function employed to sample
utility values
Per year increase
in age
-0.00029
Diabetes -0.0621
CHD -0.0557
Stroke -0.1009
Colorectal cancer -0.0378
Depression -0.1302
M. C. Gulliford et al.
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and Standard Care over 70 annual cycles, this allowed the
entire cohort to progress either to death or to reach age 100
and exit the model.
Annual transition probabilities for the model were
obtained by sampling from the beta-binomial distribution,
using GPRD data as inputs (Table 1). Utilities for each
state were obtained from data published in a compendium
of values [19] (Table 1). Utility values for each state were
stratified by single year of age but were the same for men
and women. Utility values were sampled from the beta
distribution. The costs of each state were sampled from the
gamma distribution with the mean value from GPRD, by
10-year age group, sex, condition and depression status, as
the empirical input.
Total costs and quality adjusted life years (QALYs)
were obtained by summing across the 70 cycles of the
model included in each simulation. There were 2,000
simulations run for each of intervention or standard care
scenarios. Results are expressed as rates per 1,000 healthy
participants entering the model. Mean costs, and the 95 %
range, were obtained from the data for 2,000 simulations.
Incremental costs and QALYs were obtained as the dif-
ference between intervention and standard care scenarios.
Costs and QALYs were discounted using a rate of 3.5 %,
but QALYs were also discounted at a rate of 1.5 % as a
sensitivity analysis. Incremental costs were plotted against
incremental QALYs to present a cost-effectiveness ellipse.
Net health benefits (NHB), at a threshold value of £30,000
per QALY, were calculated as the difference between the
increment in QALYs and the increment in costs divided by
the threshold value of cost per QALY. A cost-effectiveness
acceptability curve was plotted using a range of threshold
values. The model was implemented with a half cycle
correction for the estimation of QALYs and costs.
Intervention effects
The intervention was assumed to modify only the incidence
of disease in healthy participants At Risk. The effect of
intervention was estimated as a potential impact fraction
(PIF), following Cobiac et al. [20]. The PIF provides a
means of estimating the extent to which a change in risk
factor exposure is associated with a proportionate decline
in the likelihood of an individual developing a disease
outcome of interest. The PIF was estimated from three
sources of data: (1) the effect of brief interventions in
primary care on physical activity levels. Orrow et al. [6]
estimated that the number needed to treat for an additional
sedentary subject to become active was approximately 12
with an odds ratio of 1.42 (95 % confidence interval
1.17–1.73) and an event rate in control participants of 26 %
(507/1924); (2) Data for the distribution of physical
activity in the general population, by 10-year age group
and sex, were obtained from the Health Survey for England
2008 [21]; (3) Relative risks associating inactivity, or
insufficient activity, with the four study disease outcomes
(diabetes, coronary heart disease, stroke and colorectal
cancer) were obtained from the WHO study ‘Comparative
Quantification of Health Risks’ [22]. Consistent with the
WHO study we did not include a possible effect of inter-
vention on depression prevalence because the evidence is
inconsistent and disputed. The PIF was estimated as out-
lined by Cobiac et al. [20], with estimates being derived, in
each cycle, for single years of age and sex based on the
empirical estimates from the three data sources.
The intervention was modelled as being maintained for
either 5 or 10 years. In the absence of evidence for the time
course of intervention effects, the same estimates were
used to model the intervention effect in each of the first five
or ten cycles of the model as appropriate.
The cost of the intervention was modelled as a fixed cost
per person year depending on their physical activity level.
The population At Risk was divided into those that were
physically active and those that were physically inactive or
who took insufficient physical activity, based on the dis-
tribution observed in the Health Survey for England 2008.
In the population that was not sufficiently physically active
the intervention cost, in the base case, was modelled as
being equivalent to the cost of one family practice con-
sultation per person year (£35) [16]. In the population that
Table 1 continued
Data Number/value Source Stratification Comments
No. of chronic
conditions 2
-0.0615
No. of chronic
conditions 3
-0.0667
No. of chronic
conditions 4
-0.0433
No. of chronic
conditions 5
-0.0287
GPRD General practice research database, PSSRU Personal Social Services Research Unit, FDBE First DataBank Europe
Physical activity in primary care
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was physically active, the cost of screening questions to
evaluate physical activity levels was 20 % of one family
practice consultation per year. Orrow et al. reported that
‘Most [brief physical activity interventions in primary care]
included written materials and two or more sessions of
advice or counselling on physical activity, delivered face to
face’ [6]. As sensitivity analyses, therefore, we also con-
sidered costs of intervention in inactive individuals
equivalent to two family practice consultations per year
(£70) and 20 % of a family practice consultation per year
(£7).
Results
The estimated values for intervention effects, derived from
the estimated PIFs, are shown in Table 2. The figures are
the mean, standard deviation and range of values for 2,000
simulations, with each value representing the mean across
all ages in the first cycle of each simulation. An interven-
tion effect of 0.95 indicates that the incidence of the con-
dition of interest will, on average, be 5 % lower with
intervention.
There were 262,704 healthy participants, with the same
age and gender distribution as in GPRD, who entered the
model in each simulation (Table 3, Fig. 1). For an inter-
vention lasting 5 years, there was an increase in life years
lived without physical disease of 52.1 (-10.9 to 115.3) per
1,000 participants entering the model. The probability that
life years free from disease was increased was 91.9 %.
Figure 2 shows the time-course of changes in single- and
multiple-morbidity following the start of intervention. As
expected, single morbidities were reduced during the
intervention period, but the reduction in single-morbidities
persisted, while diminishing, following the end of inter-
vention. There was greater than 95 % probability that
single morbidities were reduced from the second to the
11th year following the start of intervention. A reduction in
dual morbidities reached its maximum, approximately
20 years following the start of intervention, while a
reduction in triple morbidity reached a maximum approx-
imately 30 years following the start of intervention. There
was an 87.6 % probability that life years lived with single
morbidities was reduced overall (Table 3). The equivalent
figure for dual morbidities was 73.3 %; triple morbidities,
58.7 %; and quadruple morbidities, 49.6 %. Although the
intervention was modelled to have no direct effect on
depression prevalence, overall life years with depression
tended to be reduced because of the empirical observation
that depression prevalence was higher in individuals with
morbidity.
When the intervention was maintained for 10 years, life
years lived free from disease were increased by 102.3 per
1,000 participants entering the intervention (probability
increased 99.7 %). Life years lived with single morbidities
were reduced by 69.6 per 1,000, probability 98.7 %; dual
morbidities were reduced by 16.1 per 1,000, probability,
88.9 %. There was a 69.8 % probability that life years with
triple morbidity were reduced and 76.6 % probability that
life years with depression were reduced. There was only
weak evidence that total life years were increased after
either 5 or 10 years intervention (Table 3).
Table 4 shows the changes in costs and QALYs asso-
ciated with the intervention. With an intervention of
5 years duration, the discounted incremental costs of
intervention were £97,572 per 1,000 participants entering
intervention, with 86 % of the cost attributable to inter-
vention in participants who were inactive or insufficiently
active. Approximately 14 % of the cost of intervention was
attributable to confirming the physical activity status of
participants that were already active. The costs of non-
intervention health care utilisation tended to be reduced
through intervention by -£16,818 (probability reduced
63.7 %). Thus the overall total incremental costs under
intervention were £80,744 (probability increased 95.5 %).
The discounted incremental QALYs associated with
intervention were 5.9 per 1,000 participants entering
intervention (Table 4). The probability that QALYs were
increased among the population was 75.7 %. Net Health
Benefits associated with intervention were 3.2 QALYs per
1,000 participants entering intervention. The probability
that the intervention would be cost-effective at a threshold
of £30,000 per QALY was 64.7 %.
For an intervention maintained for 10 years the overall
incremental total costs were £144,469 per 1,000. The
Table 2 Estimated values for intervention effects derived from
potential impact fractions (PIFs)
Male Female
Diabetes mellitus
Mean (SD) 0.966 (0.010) 0.967 (0.010)
Range 0.919–0.997 0.934–0.998
Coronary heart disease
Mean (SD) 0.949 (0.015) 0.951 (0.015)
Range 0.892–1.003 0.905–1.001
Stroke
Mean (SD) 0.968 (0.010) 0.969 (0.010)
Range 0.932–1.001 0.930–1.001
Colorectal cancer
Mean (SD) 0.959 (0.012) 0.961 (0.012)
Range 0.913–1.002 0.915–1.004
Figures are the mean (SD) and range for 2,000 simulations for values
in the first cycle of the model. Values may be interpreted as relative
risks
M. C. Gulliford et al.
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incremental QALYs associated with intervention were 14.9
per 1,000 (probability increased 85.1 %). The Net Health
Benefits at a threshold of £30,000 per QALY were 5.0 per
1,000. The probability of the intervention being cost-
effective at the same threshold was 72.4 %.
Figure 3 presents a cost-effectiveness plane, in which
incremental costs are plotted against incremental QALYs
for each of the 2,000 simulations. Figure 3 also presents a
cost-effectiveness acceptability curve, in which the prob-
ability of the intervention being cost-effective was
estimated at different thresholds values of cost per QALY.
An intervention continuing for either 5 or 10 years did not
achieve more than an 80 % probability of being cost-
effective, except at longer intervention duration and high
threshold values of cost per QALY, because there were
appreciable numbers of simulations in which intervention
was associated with no increase in QALYs.
Sensitivity analyses
Sensitivity analyses were implemented to explore the effects
of varying the unit costs of intervention and varying the
discount rate. As expected, increasing the unit costs of
intervention necessarily made the intervention less cost-
effective. If the cost of a 5-year intervention was equivalent
to two family practice consultations per year, then net health
benefits were approximately zero (-0.06, -14.3 to 13.6
QALYs per 1,000). However, reducing the costs of inter-
vention had only a modest effect because the proportion of
simulations in which incremental QALYs were zero or lower
set a limit to the potential increase in cost-effectiveness. If
the cost of a 5-year intervention was equivalent to 20 % of
one family practice consultation per year, then net health
benefits were 5.8 (-8.5 to 19.5 QALYs per 1,000, proba-
bility cost effective 75.1 %). When QALYs were discounted
at 1.5 % rather than 3.5 %, there was only a small difference
in the probability of the intervention proving cost effective at
5 years (probability 66.0 %) or 10 years (76.8 %), although
estimated mean net health benefits were greater, being 6.0
QALYs per 1,000 for an intervention lasting 5 years and 10.1
QALYs per 1,000 for an intervention lasting 10 years.
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Table 3 Health outcomes and cost-effectiveness of a physical activity intervention in a population of 262,704 healthy participants
Intervention duration
5 Years 10 Years
Difference
(intervention-standard care)
Probability
(%)
Difference
(intervention-standard care)
Probability
(%)
Number entering intervention 262,704 262,704
Life years lived without disease (per 1,000)a 52.1 (-10.9 to 115.3) 91.9b 102.3 (42.3 to 163.7) 99.7b
Life years lived with physical morbidity (per 1,000)a
Single condition -34.1 (-82.3 to 13.7) 87.6c -69.6 (-119.3 to -21.6) 98.7c
Dual conditions -8.3 (-29.1 to 12.6) 73.3c -16.1 (-38.8 to 5.7) 88.9c
Triple conditions -0.96 (-8.0 to 5.7) 58.7c -2.0 (-9.0 to 5.0) 69.8c
Quadruple conditions -0.01 (-1.4 to 1.4) 49.6c -0.1 (-1.5 to 1.3) 53.6c
Life years lived with depression (per 1,000)a -2.8 (-17.9 to 11.8) 61.9c -6.4 (-20.4 to 7.9) 76.6c
Total life years (per 1,000)a 8.9 (-35.6 to 52.3) 62.7b 14.6 (-29.2 to 59.3) 71.1b
Figures represent mean and 95 % range of 2,000 simulations
a Per 1,000 healthy participants entering model
b Probability measure is higher with intervention
c Probability measure is lower with intervention
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Discussion
What this study shows
This study modelled the health outcomes of a universal
intervention, aimed at all healthy adults, to promote
physical activity in primary care. The study employed an
empirical population of adults registered with UK family
practices; the size of the population at risk was equivalent
in size to that of a small town or a primary care organi-
sation. The intervention effect was derived from a
meta-analysis of randomised controlled trials, based on the
distribution of physical activity observed in a representa-
tive population sample in England. The results show that
an intervention with only a small effect on the risk of
disease may yield appreciable health benefits including an
increase in life years lived free from physical disease and a
reduction in life years lived with either single or multiple
comorbidity. An important finding from this study is that
interventions, or intervention effects in terms of behav-
ioural changes resulting from intervention, must be main-
tained over prolonged periods of time in order for
substantial health benefits to accumulate. This long time
scale for the emergence of health benefits presents a
challenge in allocating primary care resources to delayed
rather than immediate benefits. The present results suggest
that a brief intervention in primary care represents a costly
way of achieving population-wide outcomes. Even when
the intervention is delivered at very low unit cost, there is
only weak evidence that the intervention could have
acceptable cost-effectiveness. These results therefore offer
only limited support to continued investigation of a uni-
versal intervention as part of a standard family practice
visit. Future research should evaluate whether interventions
targeted at high-risk individuals may be more suitable for
utilisation in primary care, with population strategies being
delivered through multi-sectoral interventions.
What other studies show
Hillsdon’s [23] review of interventions to promote physical
activity included studies published up to 2004. Of the 29
studies, 15 were set in primary care, including a range of
intervention and follow-up methods. The overall increase
in physical activity through intervention amounted to 0.28
standard deviations (SD) for a physical activity measure,
with a 0.52 SD increase in physical fitness in 11 studies.
This review provides evidence that interventions in pri-
mary care to promote physical activity may be effective, at
least in the short term. These conclusions are supported by
more recent systematic reviews [6, 24]. However, indi-
vidual level behavioural interventions to promote physical
activity may be more costly that we have estimated for this
study. Muller-Reimenschneider found a value of Euro 800
per year [25]. Recent studies suggest that community-wide
or environmental interventions aimed at increasing use of
leisure facilities [26] or promoting active travel [27] may
have more acceptable cost-effectiveness.
Table 4 Health outcomes and cost-utility of a physical activity intervention in a population of 262,704 healthy participants
Intervention duration
5 years 10 years
Difference (intervention-
standard care)
Probability
(%)
Difference (intervention-
standard care)
Probability
(%)
Number entering intervention 262,704 262,704
Intervention costs in physically active (£ per 1,000) 13,995 (13,989 to 14,001) 100.0 24,018 (24,003 to 24,033) 100.0
Intervention costs in physically inactive (£ per 1,000) 83,567 (83,531 to 83,601) 100.0 152,210 (152,110 to
152,306)
100.0
Total intervention costs (£ per 1,000) 97,572 (97,521 to 97,602) 100.0 176,228 (176,113 to
176,340)
100.0
Incremental costs of non-intervention health care
utilisation (£ per 1,000)
-16,818 (-94,269 to
60,747)
63.7b -31,760 (-109,077 to
47,599)
74.3b
Incremental total costs (£ per 1,000)a 80,744 (3,326 to 158,251) 95.5 144,469 (67,103 to 223,843) 99.9
Incremental QALYs (discounted 3.5 %) (per 1,000) 5.9 (-8.2 to 19.7) 75.7 9.8 (-4.6 to 23.6) 87.3
Incremental QALYs (discounted 1.5 %) (per 1,000) 8.6 (-14.7 to 32.4) 72.7 14.9 (-8.7 to 38.5) 85.1
Net health benefits (QALYs per 1,000) 3.2 (-11.1 to 16.9) 64.7 5.0 (-9.5 to 19.3) 72.4
Probability cost effective at £30,000 per QALY (%) 64.7 72.4
Figures represent mean and 95 % range of 2,000 simulations. QALY Quality-adjusted life year, CHD coronary heart disease
a Per 1,000 healthy participants entering model
b Probability reduced
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Strengths and limitations of this study
This research was grounded in data from a very large cohort
of participants from primary care, which provided strong
empirical evidence to construct the model. Nevertheless,
some multi-disease states were less frequent, leading to
imprecise estimates. There were numerous estimates for
incidence, mortality, prevalence of depression, as well as
health care utilisation contributing to stochastic error in the
Model inputs and consequently to uncertainty in the Model
outputs. Utility values were drawn from a secondary source
because it was not feasible to obtain primary data for multiple
disease states within the context of this study. The QALY
estimates in this source rely on a US-based survey. While our
study is UK-based, this secondary data source provided
consistent estimates covering the number of disease states in
this research. Uncertainty in utility estimates was incorpo-
rated into the Model through the probabilistic approach.
Sensitivity analyses were implemented to study the effect of
varying key parameters. We did not set an upper age limit to
eligibility for intervention because physical activity is ben-
eficial even in old age [28]. The model included only a
limited range of health conditions and it is possible that there
are wider health benefits of intervention that were not
included. The model assumed that mortality reductions
would be achieved only through the conditions of interest and
not by reductions in mortality from other causes [29]. The
model did not include secular trends in the measures of
interest because the direction of future trends is unknown.
We acknowledge that true long-term intervention effects
are not known and the model requires an important
assumption that short-term effects must be maintained if
the intervention is continued. We used results from a meta-
analysis of randomised trials to provide an estimate of the
intervention effect. However, most of the included studies
used self-reported measures of physical activity and a
similar effect has not been demonstrated employing
objective measures. In a probabilistic framework, we used
the standard error to model random error in the point
estimate of the intervention effect. The intervention time
course is also unknown and we did not model scenarios in
which the effect of intervention might outlast the inter-
vention itself. We also did not assume any social multiplier
effects in our modelling where the impact of one person
taking on more physical exercise might influence others’
around him therefore possibly underestimating intervention
effect size. Intervention effects were not allowed to vary in
different population groups but we intend to study this
further in future studies. We modelled several different
estimates for intervention costs. It is clear that an inter-
vention of very low cost has only a limited probability of
proving cost-effective, with a more costly intervention
yielding little or no net benefit. However, more complex
scenarios could be envisaged in which the major costs may
be incurred at the start, with lower maintenance costs. The
model included only health care costs; conclusions might
differ appreciably if other costs and productivity changes
were to be included. In particular, the opportunity costs of
leisure-time physical activity are important [30]. The data
were obtained from primary care records and utilisation of
secondary care may also have been underestimated as we
could not follow patient use of secondary care resources
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Fig. 3 Left panel Cost-effectiveness plane showing results of 2,000 simulations with 10 years’ intervention. Outer ellipse encompasses 95 % of
simulations. Right panel Cost-effectiveness acceptability curves for 5 (blue) and 10 (red) years intervention (color figure online)
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beyond referral and admission. We used the average of
costs over all stages of a disease but this is a simplification
because, in reality, costs may be higher at the start of the
illness, or at periods closer to death. We caution that most
estimates included in the Model derived from the British
primary health care system. Costs and outcomes may be
different in other countries and settings where resource use,
the costs of care, and levels of physical activity and barriers
to physical activity may be different.
Conclusions
The results contribute new information towards under-
standing the potential for a universal strategy for physical
activity promotion in primary care. Firstly, an important
increase in time lived free from physical disease, and a
reduction in the time lived with single or multiple mor-
bidity, may result from even a modest increase in physical
activity levels. Secondly, intervention effects must be
maintained over a prolonged period of time in order for
substantial health benefits to be realised, though these may
continue to accumulate after the end of the intervention.
Individuals receiving the intervention must effectively
change lifelong behaviours in order to benefit. Thirdly,
even when interventions can be delivered over the long-
term at low annual cost, such as the cost of an additional
family practice consultation each year, there is only weak
evidence that the intervention might have acceptable cost-
effectiveness when employed in a universal strategy. The
present results emphasise that physical activity is a deter-
minant of health important to primary care professionals,
but also show that implementation of a universal strategy
within primary care faces several challenges. While the
results indicate some potential for a universal strategy, an
alternative approach, which will be evaluated in future
research, is the delivery of a selective or targeted strategy
to focus intervention efforts on those at higher risk of
disease.
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